For IV administration, a dose is usually 10-20 mg per kilogram of body weight
for instance, DT-109 (Gly-Gly-Leu) markedly reduced atherosclerosis and vascular calcification in nonhuman primates, underscoring the translational potential of tripeptide-based therapeutics for cardiovascular diseases [181]
For the co-primary endpoint of the proportion of people attaining at least a 5% reduction in their baseline bodyweight, the corresponding values were 85%, 89%, and 91% versus 35%
However, according to the National Institute of Child Health and Human Development, folic acid supplementation reduces the risk of neural tube defects in all pregnant women, including women with an MTHFR variant
Some patients use it twice daily depending on their goals
Coordinating Tirzepatide with other peptides requires no special timing